These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro. Wang JH, Tam SC, Huang H, Ouyang DY, Wang YY, Zheng YT. Biochem Biophys Res Commun; 2004 May 14; 317(4):965-71. PubMed ID: 15094363 [Abstract] [Full Text] [Related]
25. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants. Thorpe PE, Blakey DC, Brown AN, Knowles PP, Knyba RE, Wallace PM, Watson GJ, Wawrzynczak EJ. J Natl Cancer Inst; 1987 Nov 14; 79(5):1101-12. PubMed ID: 2890786 [Abstract] [Full Text] [Related]
29. New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. Thorpe PE, Wallace PM, Knowles PP, Relf MG, Brown AN, Watson GJ, Knyba RE, Wawrzynczak EJ, Blakey DC. Cancer Res; 1987 Nov 15; 47(22):5924-31. PubMed ID: 3499221 [Abstract] [Full Text] [Related]
32. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer. Byers VS, Rodvien R, Grant K, Durrant LG, Hudson KH, Baldwin RW, Scannon PJ. Cancer Res; 1989 Nov 01; 49(21):6153-60. PubMed ID: 2790828 [Abstract] [Full Text] [Related]
33. [Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice]. Chen GF, Huang WG, Chen FY, Shan JL. Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun 01; 8(3):239-41. PubMed ID: 16787600 [Abstract] [Full Text] [Related]
36. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin. Griffin TW, Pagnini PG, Houston LL. J Biol Response Mod; 1987 Oct 01; 6(5):537-45. PubMed ID: 3500277 [Abstract] [Full Text] [Related]
37. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas. Griffin TW, Pagnini PG, McGrath JJ, McCann JC, Houston LL. J Biol Response Mod; 1988 Dec 01; 7(6):559-67. PubMed ID: 3265147 [Abstract] [Full Text] [Related]
38. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line. Tejuca M, Díaz I, Figueredo R, Roque L, Pazos F, Martínez D, Iznaga-Escobar N, Pérez R, Alvarez C, Lanio ME. Int Immunopharmacol; 2004 Jun 01; 4(6):731-44. PubMed ID: 15135315 [Abstract] [Full Text] [Related]
39. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis. An Q, Wei S, Mu S, Zhang X, Lei Y, Zhang W, Jia N, Cheng X, Fan A, Li Z, Xu Z. J Biomed Sci; 2006 Sep 01; 13(5):637-43. PubMed ID: 16977428 [Abstract] [Full Text] [Related]
40. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen. Hwang KM, Foon KA, Cheung PH, Pearson JW, Oldham RK. Cancer Res; 1984 Oct 01; 44(10):4578-86. PubMed ID: 6467213 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]